Date: 2011-09-07
Type of information: Fundraising
Company: PolyTherics (UK)
Investors: The financing round was led by Imperial Innovations Group plc (AIM: IVO), with participation from existing investor The Capital Fund, which is managed by YFM Equity Partners, and new investor Proven Health VCT PLC (LON: PHV).
Amount: £2.15 million (€2.4 million)
Funding type: financing round
Planned used: The funds will be used to apply the company’s proprietary polymer-protein conjugation technologies to an expanding range of proteins and peptides and to pursue new applications of these technologies.
Others: PolyTherics, a solution provider to biopharmaceutical companies for the improvement of protein and peptide based drugs, has raised £2.15 million of new finance. This investment follows on previous financing rounds in 2007 and 2010 which raised £5.3 million from Imperial Innovations, Longbow Capital and The Capital Fund.
Therapeutic area: Technology - Services
